{"product_id":"respiratory-test-kit-tyfast-flu-a-b-covid-19-multiplex-rapid-test-25-tests","title":"Respiratory Test Kit Tyfast Flu A+B \/ COVID-19 Multiplex Rapid Test 25 Tests","description":"\u003cul\u003e\n\u003cli\u003eThe CorDx Tyfast Flu A\/B \u0026amp; COVID-19 Multiplex Rapid Test is only for in vitro diagnostic use under the Food and Drug Administration’s Emergency Use Authorization:\u003c\/li\u003e\n\u003cli\u003eProduct ships with minimum 90 days dating\u003c\/li\u003e\n\u003cli\u003eThe CorDx Tyfast Flu A\/B \u0026amp; COVID-19 Multiplex Rapid Test is a lateral flow immunochromatographic assay intended for in vitro rapid, simultaneous qualitative detection and differentiation of influenza A and influenza B nucleoprotein antigens and SARS-CoV-2 nucleocapsid antigen directly from anterior nasal swab specimens of individuals with signs and symptoms of respiratory infection consistent with COVID-19 by their healthcare provider within the first five (5) days of symptom onset when tested at least twice over three days with at least 48 hours between tests\u003c\/li\u003e\n\u003cli\u003eThe test provides an efficient and accurate diagnostic solution in 10 mins, giving healthcare providers and communities a rapid and reliable way to prioritize their health\u003c\/li\u003e\n\u003cli\u003eTesting is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. § 263a, that meet the requirements to perform moderate, high or waived complexity tests\u003c\/li\u003e\n\u003cli\u003eThis test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation\u003c\/li\u003e\n\u003cli\u003eResults are for the simultaneous in vitro detection and differentiation of SARS-CoV-2, influenza A virus, and influenza B virus protein antigens, but do not differentiate, between SARS-CoV and SARS-CoV-2 viruses and are not intended to detect influenza C antigens\u003c\/li\u003e\n\u003cli\u003ePositive results do not rule out bacterial infection or co-infection with other viruses\u003c\/li\u003e\n\u003cli\u003eNegative results do not rule out influenza or SARS-CoV-2 infection, and should not be used as the sole basis for treatment or patient management decisions, including infection control measures such as isolating from others and wearing masks\u003c\/li\u003e\n\u003cli\u003eNegative results should be considered in the context of an individual’s recent exposures, history and the presence of clinical signs and symptoms consistent with each respiratory infection\u003c\/li\u003e\n\u003cli\u003ePatient Population: The test is designed for individuals aged 2 years and older with symptoms of COVID-19 and\/or influenza A and B within the first 5 days of symptom onset\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003eProduct Specs\u003c\/h3\u003e\u003ctable\u003e\u003ctbody\u003e\n\u003ctr\u003e\n\u003cth\u003eItem Number\u003c\/th\u003e\n\u003ctd\u003e1265432\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eCatalog Number\u003c\/th\u003e\n\u003ctd\u003eACT21001-25\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eUOM\u003c\/th\u003e\n\u003ctd\u003eBX\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eLevel 1 Family Description\u003c\/th\u003e\n\u003ctd\u003eLab-Waived Lab\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eLevel 2 Category Description\u003c\/th\u003e\n\u003ctd\u003eLab-Respiratory Testing\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eLevel 3 Group Description\u003c\/th\u003e\n\u003ctd\u003eCombo Tests\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eLevel 4 Sub-Category Description\u003c\/th\u003e\n\u003ctd\u003eCombo - Visually Read\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eApplication\u003c\/th\u003e\n\u003ctd\u003eRespiratory Test Kit\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eBrand\u003c\/th\u003e\n\u003ctd\u003eTyfast\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eBuy American Act (BAA) Compliant\u003c\/th\u003e\n\u003ctd\u003eYes\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eContents 1\u003c\/th\u003e\n\u003ctd\u003e(25) Test Cassettes, (25) Swabs, (25) Tubes with Sample Processing Solution, IFU, Quick Ref Guide\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eCountry of Origin\u003c\/th\u003e\n\u003ctd\u003eUnited States\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eManufacturer\u003c\/th\u003e\n\u003ctd\u003eCorDx Inc\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eManufacturer #\u003c\/th\u003e\n\u003ctd\u003eACT21001-25\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eMcKesson #\u003c\/th\u003e\n\u003ctd\u003e1265432\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eNumber of Tests\u003c\/th\u003e\n\u003ctd\u003e25 Tests\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003ePurchase Program Type\u003c\/th\u003e\n\u003ctd\u003eStandard Purchase\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eReading Type\u003c\/th\u003e\n\u003ctd\u003eVisual Read\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eSample Type\u003c\/th\u003e\n\u003ctd\u003eAnterior Nasal Swab Sample\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eSpecialty\u003c\/th\u003e\n\u003ctd\u003eImmunoassay\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eTest Format\u003c\/th\u003e\n\u003ctd\u003eCassette Format\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eTest Kit Type\u003c\/th\u003e\n\u003ctd\u003eRapid\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eTest Method\u003c\/th\u003e\n\u003ctd\u003eLateral Flow\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eTest Name\u003c\/th\u003e\n\u003ctd\u003eFlu A+B \/ COVID-19 Multiplex Rapid Test\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eTime to Results\u003c\/th\u003e\n\u003ctd\u003e10 Minute Results\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eTrade Agreement Act (TAA) Compliant\u003c\/th\u003e\n\u003ctd\u003eYes\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eUNSPSC Code\u003c\/th\u003e\n\u003ctd\u003e41116144\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\u003c\/table\u003e","brand":"CorDx Inc","offers":[{"title":"Default Title","offer_id":42965462384717,"sku":"CDX-ACT21001-25","price":228.41,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1046\/1086\/files\/1265432_pkgright.jpg?v=1780281656","url":"https:\/\/mfimedical.com\/products\/respiratory-test-kit-tyfast-flu-a-b-covid-19-multiplex-rapid-test-25-tests","provider":"MFI Medical","version":"1.0","type":"link"}